Skip to main content

and
  1. Article

    Open Access

    Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection

    The presentation of peptides and the subsequent immune response depend on the MHC characteristics and influence the specificity of the immune response. Several studies have found an association between HLA var...

    Johannes C. Fischer, Vera Balz, Danny Jazmati in European Journal of Medical Research (2022)

  2. Article

    Open Access

    Acute cardiac side effects after COVID-19 mRNA vaccination: a case series

    Vaccination against SARS-CoV-2 has been the main tool to contain the pandemic. The rush development of the 3 vaccines and their expedited approval have led to inoculation of millions of patients around the wor...

    Noemi F. Freise, Milena Kivel, Olaf Grebe in European Journal of Medical Research (2022)

  3. Article

    Open Access

    Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19

    COVID-19, the pandemic disease caused by infection with SARS-CoV-2, may take highly variable clinical courses, ranging from symptom-free and pauci-symptomatic to fatal disease. The goal of the current study wa...

    Johannes C. Fischer, Albrecht G. Schmidt in European Journal of Medical Research (2021)

  4. Article

    Open Access

    Correction to: Informed consent and informed intervention: SARS‑CoV‑2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing

    Johannes C. Fischer, Albrecht G. Schmidt in European Journal of Medical Research (2021)

  5. Article

    Open Access

    Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction

    The coronavirus disease 2019 (COVID‐19) is associated with a wide clinical spectrum of skin manifestations, including urticarial, vesicular, vasculitic and chilblain‐like lesions. Recently, delayed skin reacti...

    Norman-Philipp Hoff, Noemi F. Freise in European Journal of Medical Research (2021)

  6. Article

    Open Access

    Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing

    COVID-19 infection is a major threat to patients and health care providers around the world. One solution is the vaccination against SARS-CoV-2.

    Johannes C. Fischer, Albrecht G. Schmidt in European Journal of Medical Research (2021)

  7. Article

    Open Access

    Correction to: The role of passive immunization in the age of SARS-CoV-2: an update

    An amendment to this paper has been published and can be accessed via the original article.

    Johannes C. Fischer, Kurt Zänker in European Journal of Medical Research (2020)

  8. Article

    Open Access

    Face masks: benefits and risks during the COVID-19 crisis

    The German government has made it mandatory to wear respiratory masks covering mouth and nose (MNC) as an effective strategy to fight SARS-CoV-2 infections. In many countries, this directive has been extended ...

    Christiane Matuschek, Friedrich Moll in European Journal of Medical Research (2020)

  9. Article

    Open Access

    The history and value of face masks

    In the human population, social contacts are a key for transmission of bacteria and viruses. The use of face masks seems to be critical to prevent the transmission of SARS-CoV-2 for the period, in which therap...

    Christiane Matuschek, Friedrich Moll in European Journal of Medical Research (2020)

  10. Article

    Open Access

    The role of passive immunization in the age of SARS-CoV-2: an update

    The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-...

    Johannes C. Fischer, Kurt Zänker in European Journal of Medical Research (2020)